BDMAI

Infinite Right-to-Left Scrolling Marquee
Latest Circulars

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Updates

S.NO. Title Document
1
Industry Performance Metrics: Insights from US FDA Inspection Data
2
The Indian Bulk Drug Industry Holds Strategic Importance in Strengthening Global Supply Chain Resilience
3
Optimising Pharmaceutical Process
4
Guidelines of Scheme Strengthening of Pharmaceutical Industries (SPI)
5
Information on Delta Carbon – Advanced bio based Material
6
Energy Efficient Cooling Solutions for API From Thermax
7
Report-Drug resistant bacteria in and around Pharmaceutical Manufacturing Clusters of Hyderabad
8
New Drug Therapy Approvals 2024
9
Fortifying API Supply Chains 2025 and Beyond: Aligning Current Strengths with Future Opportunities for Better Patient Outcomes
10
Process Validation: The Life Cycle Approach
11
The NDMA Story: Lessons Learned from a Global Pharmaceutical Challenge
12
Future Forward: How Gender Diversity Can Transform the Indian Bulk Drug Industry

© 2021 Templately copyright all right reserved